Indapamid Stada

Indapamide, the active ingredient in Indapamid Stada, is a thiazide‑like diuretic presented as an oral tablet for oral use. It treats hypertension and edema associated with congestive heart failure in adult patients, providing blood pressure control and fluid reduction under medical supervision.

GNH USA supplies Indapamid Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, and clinics worldwide, with a focus on reliable quality, regulatory compliance, and timely delivery across multiple regions. Our global logistics network ensures consistent product availability and compliance with local regulatory requirements.

Indapamide is a thiazide‑like diuretic that lowers blood pressure and reduces fluid overload.

Hypertension: reduces systolic and diastolic pressure by promoting natriuresis. Edema associated with congestive heart failure: decreases extracellular fluid volume, relieving peripheral swelling. Renal impairment‑related hypertension: aids in blood pressure management when used with caution.

Indapamide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness - Headache - Increased urination - Electrolyte imbalance (e.g., low potassium) - Nausea

Serious or Rare Side Effects: - Severe dehydration - Hyponatremia or hypokalemia leading to cardiac arrhythmia - Gout attacks - Allergic reactions such as rash or angioedema - Blood dyscrasias (e.g., agranulocytosis)

When prescribing Indapamide, several safety considerations should be observed.

Monitor electrolytes: check serum potassium and sodium regularly. Assess renal function: avoid use in severe renal impairment. Avoid abrupt discontinuation: may cause rebound hypertension. Pregnancy category B: use only if benefit outweighs risk. Drug interactions: review concomitant medications for potential additive effects. Store at ambient temperature: keep in the original container, protect from moisture and light.

Indapamide can interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - Lithium: may increase lithium toxicity. - NSAIDs: may reduce diuretic efficacy and impair renal function. - ACE inhibitors or ARBs: risk of severe hypotension and electrolyte imbalance.

Moderate Interactions (Monitor Closely): - Beta‑blockers: additive blood‑pressure‑lowering effect. - Digoxin: heightened risk of hypokalemia‑related toxicity. - Antidiabetic agents: may enhance hypoglycaemic response.